These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2184878)

  • 21. Superficial bladder disease: case studies and therapeutic advances.
    Soloway MS; Droller MJ; Flanigan RC; Nseyo UO
    Urology; 1992 Dec; 40(6 Suppl):11-22. PubMed ID: 1466118
    [No Abstract]   [Full Text] [Related]  

  • 22. Managing superficial bladder cancer: an overview.
    Soloway MS
    Urology; 1992 Dec; 40(6 Suppl):5-10. PubMed ID: 1466119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miliary tuberculosis secondary to transurethral bacillus Calmette-Guérin administration for superficial transitional cell carcinoma of the bladder.
    Skoutelis A; Melekos MD; Bassaris HJ
    J Natl Cancer Inst; 1990 Jul; 82(14):1219-20. PubMed ID: 2362292
    [No Abstract]   [Full Text] [Related]  

  • 24. [BCG therapy of superficial tumors of the bladder].
    Prapotnich D
    Bull Cancer; 1998 Feb; 85(2):135-9. PubMed ID: 9752330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical sequential combination of epirubicin and interferon alpha-2b in patients affected by superficial transitional cell carcinoma of the bladder. Results of a pilot study at Palermo University and proposal of a basic research.
    Serretta V; Corselli G; Pavone C; Pizzuto Antinoro SA; Pavone-Macaluso M
    Prog Clin Biol Res; 1991; 370():185-93. PubMed ID: 1924449
    [No Abstract]   [Full Text] [Related]  

  • 26. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
    Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
    J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When intravesical measures fail. Indications for cystectomy in superficial disease.
    Hudson MA
    Urol Clin North Am; 1992 Aug; 19(3):601-9. PubMed ID: 1636242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
    Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
    Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.
    Pawinski A; Sylvester R; Bouffioux C; Kurth KH; Parmar M; Bijnens L
    Acta Urol Belg; 1996 May; 64(2):27. PubMed ID: 8701803
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intravesical chemotherapy with interferon in superficial bladder tumors].
    Tanahashi T; Matsumura Y; Yoshimoto J; Tsushima T; Obama T; Akagi T; Ochi J; Hara M; Saegusa M; Ohmori H
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1156-9. PubMed ID: 3105469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
    Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Standards and perspectives in diagnosis and therapy of bladder carcinoma].
    Stief C; Zaak D; Stöckle M; Studer U; Knuechel R; Rödel C; Sauer R; Rubben H
    Urologe A; 2006 Sep; 45 Suppl 4():90-6. PubMed ID: 16896761
    [No Abstract]   [Full Text] [Related]  

  • 34. Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy.
    Badalament RA; Ortolano V; Burgers JK
    Urol Clin North Am; 1992 Aug; 19(3):485-98. PubMed ID: 1636233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ
    Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe self-limiting hypersensitivity reaction after immunotherapy with intravesical BCG].
    Estelles Piera FJ; Campayo A; Valls Ferrer JM; Lacruz J; Blanes Julia FM; López Aldeguer J; Bonora Tamarit V
    An Med Interna; 1994 Oct; 11(10):503-5. PubMed ID: 7865660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental chemotherapy of bladder cancer--systemic and intravesical.
    Soloway MS; Murphy WM
    Semin Oncol; 1979 Jun; 6(2):166-83. PubMed ID: 384516
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intravesical instillation in the treatment of superficial tumors of the bladder].
    Chopin DK
    Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometry correlates of response to intravesical interferon.
    Bonney WW; Rosenberg SJ; Kluskens LF; Yen A; Henry KM; Williams RD
    Prog Clin Biol Res; 1988; 260():203-14. PubMed ID: 3362880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.